Search Results

Search Results for

S2000

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

Continue Reading »
Nektar 20-214-29

Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence (PIVOT-12)

Continue Reading »
EA6192

Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial

Continue Reading »
MK7902-003

Safety and Efficacy Study of Pembrolizumab (MK-3475) Combined With Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Advance Melanoma (MK-7902-003/E7080-G000-312/LEAP-003)

Continue Reading »
A091802

Avelumab With or Without Cetuximab in Treating Patients With Advanced Skin Squamous Cell Cancer

Continue Reading »
S1801

Pembrolizumab in Treating Patients With Stage III-IV High-Risk Melanoma Before and After Surgery

Continue Reading »
EA6134

Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma

Continue Reading »

Search Again